<VariationArchive VariationID="526631" VariationName="NC_000020.11:g.(?_3889081)_(3912654_?)del" VariationType="Deletion" Accession="VCV000526631" Version="8" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-04-06" DateCreated="2018-05-28" MostRecentSubmission="2023-11-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="533507" VariationID="526631">
      <GeneList>
        <Gene Symbol="LOC125384566" FullName="Sharpr-MPRA regulatory region 6416" GeneID="125384566" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>20p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3896302" stop="3896596" display_start="3896302" display_stop="3896596" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130065344" FullName="ATAC-STARR-seq lymphoblastoid silent region 12634" GeneID="130065344" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>20p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3889022" stop="3889081" display_start="3889022" display_stop="3889081" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130065345" FullName="ATAC-STARR-seq lymphoblastoid silent region 12635" GeneID="130065345" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>20p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3889272" stop="3889771" display_start="3889272" display_stop="3889771" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130065346" FullName="ATAC-STARR-seq lymphoblastoid active region 17488" GeneID="130065346" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>20p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3897613" stop="3897842" display_start="3897613" display_stop="3897842" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130065347" FullName="ATAC-STARR-seq lymphoblastoid active region 17489" GeneID="130065347" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>20p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3906738" stop="3906817" display_start="3906738" display_stop="3906817" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="PANK2" FullName="pantothenate kinase 2" GeneID="80025" HGNC_ID="HGNC:15894" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20p13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="3888781" stop="3929887" display_start="3888781" display_stop="3929887" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="3869485" stop="3904501" display_start="3869485" display_stop="3904501" Strand="+" />
          </Location>
          <OMIM>606157</OMIM>
        </Gene>
      </GeneList>
      <Name>NC_000020.11:g.(?_3889081)_(3912654_?)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>20p13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" innerStart="3889081" innerStop="3912654" display_start="3889081" display_stop="3912654" variantLength="23574" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" innerStart="3869728" innerStop="3893301" display_start="3869728" display_stop="3893301" variantLength="23574" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.(?_3889081)_(3912654_?)del" Assembly="GRCh38">
            <Expression>NC_000020.11:g.(?_3889081)_(3912654_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.(?_3869728)_(3893301_?)del" Assembly="GRCh37">
            <Expression>NC_000020.10:g.(?_3869728)_(3893301_?)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NC_000020.11:g.(?_3889081)_(3912654_?)del AND Pigmentary pallidal degeneration" Accession="RCV000631207" Version="7">
        <ClassifiedConditionList TraitSetID="1251">
          <ClassifiedCondition DB="MedGen" ID="C0018523">Pigmentary pallidal degeneration</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2021-08-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2021-08-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-05-28" MostRecentSubmission="2023-11-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11479594</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">12510040</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16437574</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1251" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3087" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">HARP SYNDROME</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pigmentary pallidal degeneration</ElementValue>
                <XRef ID="Pigmentary+pallidal+degeneration/9108" DB="Genetic Alliance" />
                <XRef ID="2992000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PKAN NEUROAXONAL DYSTROPHY, JUVENILE-ONSET</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neurodegeneration with brain iron accumulation 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Neuroaxonal dystrophy, late infantile</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hallervorden-Spatz disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pantothenate kinase-associated neurodegeneration</ElementValue>
                <XRef ID="MONDO:0009319" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">PKAN</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Preferred">NBIA1</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HARP</ElementValue>
                <XRef Type="MIM" ID="234200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6564" />
                <XRef ID="6564" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pantothenate kinase-associated neurodegeneration (PKAN) is a type of neurodegeneration with brain iron accumulation (NBIA). The phenotypic spectrum of PKAN includes classic PKAN and atypical PKAN. Classic PKAN is characterized by early-childhood onset of progressive dystonia, dysarthria, rigidity, and choreoathetosis. Pigmentary retinal degeneration is common. Atypical PKAN is characterized by later onset (age &gt;10 years), prominent speech defects, psychiatric disturbances, and more gradual progression of disease.</Attribute>
                <XRef ID="NBK1490" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301663</ID>
                <ID Source="BookShelf">NBK1490</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">23447832</ID>
                <ID Source="BookShelf">NBK121988</ID>
              </Citation>
              <XRef ID="157850" DB="Orphanet" />
              <XRef ID="C0018523" DB="MedGen" />
              <XRef ID="MONDO:0009319" DB="MONDO" />
              <XRef Type="MIM" ID="234200" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="1461648" SubmissionDate="2023-02-03" DateLastUpdated="2023-11-11" DateCreated="2018-05-28">
        <ClinVarSubmissionID localKey="NM_153638.2_20_Deletion (exons 1-4)|MedGen:C0018523" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000752221" DateUpdated="2023-11-11" DateCreated="2018-05-28" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-08-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">11479594</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">12510040</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16437574</ID>
          </Citation>
          <Comment>This variant is a gross deletion of the genomic region encompassing exon(s) 1-4 of the PANK2 gene, which includes the initiator codon. The 5' end of this event is unknown as it extends beyond the assayed region for this gene and therefore may encompass additional genes. The 3' boundary is likely confined to intron 4 of the PANK2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PANK2 are known to be pathogenic (PMID: 11479594, 12510040). A similar copy number variant has been observed in individuals with pantothenate kinase-associated neurodegeneration (PMID: 16437574). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PANK2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.(?_3869728)_(3893301_?)del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0018523" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB3864685</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="1461648" TraitType="Disease" MappingType="XRef" MappingValue="C0018523" MappingRef="MedGen">
        <MedGen CUI="C0018523" Name="Pigmentary pallidal degeneration" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

